FELIPE
GÓMEZ CAMINERO LÓPEZ
Investigador Predoctoral
Universitat de Barcelona
Barcelona, EspañaUniversitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors
CASE REPORTS IN ONCOLOGICAL MEDICINE, Vol. 2021